Cargando…

Association of Klotho gene Expression and miRNA- 339 in Schizophrenia

INTRODUCTION: Schizophrenia is one of the major neuropsychiatric disorders affecting 1% of the population worldwide. Neuroinflammation, neurodevelopment, and oxidative stress are some of the crucial factors that can contribute to the pathogenesis of Schizophrenia. The Klotho gene is an antiaging gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, D., Birdi, A., Tomo, S., Nebhinani, N., Sharma, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596670/
http://dx.doi.org/10.1192/j.eurpsy.2023.590
_version_ 1785125159611400192
author Yadav, D.
Birdi, A.
Tomo, S.
Nebhinani, N.
Sharma, P.
author_facet Yadav, D.
Birdi, A.
Tomo, S.
Nebhinani, N.
Sharma, P.
author_sort Yadav, D.
collection PubMed
description INTRODUCTION: Schizophrenia is one of the major neuropsychiatric disorders affecting 1% of the population worldwide. Neuroinflammation, neurodevelopment, and oxidative stress are some of the crucial factors that can contribute to the pathogenesis of Schizophrenia. The Klotho gene is an antiaging gene whose dysregulated expression can lead to Schizophrenia and aging-like symptoms in patients. Klotho gene expression is regulated by miRNA- 339, which might lead to expression changes of the klotho gene in schizophrenia patients. OBJECTIVES: This study aimed to determine the role of miRNA- 339-5p in the regulation of Klotho gene expression and its circulatory levels in Schizophrenia METHODS: A total of 60 diagnosed patients with Schizophrenia per ICD 10 study subjects and 30 healthy controls were recruited for this study from the outpatient department of psychiatry of All India Institute of Medical Sciences, Jodhpur. Written informed consent was taken from all the study participants. All participants were given the right to withdraw from the study at any point in time. The institutional ethics committee of AIIMS, Jodhpur, approved this study. The expression analysis of the klotho gene and miRNA – 339-5p was performed using a reverse transcription polymerase chain reaction. The relative fold change expression was calculated by Livaak’s method ( 2^-double delta ct). RESULTS: In Schizophrenia cases, serum Klotho protein levels were higher than healthy controls, though non-significant. We observed that the klotho gene was upregulated (figure 1), and miRNA- 339- 5p was downregulated (figure 2) compared to the healthy control. Image: Image 2: CONCLUSIONS: The present study is the first to evaluate the klotho gene expression and correlate it with miRNA- 339- 5p. Our study found increased expression of the klotho gene in Schizophrenia patients as compared to the controls. In this study, we also observed that miRNA- 339- 5p was downregulated, which correlates with the klotho gene expression inversely. However, these are the preliminary findings due to less sample size and need to be replicated in the large sample size for further confirmation. DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-10596670
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-105966702023-10-25 Association of Klotho gene Expression and miRNA- 339 in Schizophrenia Yadav, D. Birdi, A. Tomo, S. Nebhinani, N. Sharma, P. Eur Psychiatry Abstract INTRODUCTION: Schizophrenia is one of the major neuropsychiatric disorders affecting 1% of the population worldwide. Neuroinflammation, neurodevelopment, and oxidative stress are some of the crucial factors that can contribute to the pathogenesis of Schizophrenia. The Klotho gene is an antiaging gene whose dysregulated expression can lead to Schizophrenia and aging-like symptoms in patients. Klotho gene expression is regulated by miRNA- 339, which might lead to expression changes of the klotho gene in schizophrenia patients. OBJECTIVES: This study aimed to determine the role of miRNA- 339-5p in the regulation of Klotho gene expression and its circulatory levels in Schizophrenia METHODS: A total of 60 diagnosed patients with Schizophrenia per ICD 10 study subjects and 30 healthy controls were recruited for this study from the outpatient department of psychiatry of All India Institute of Medical Sciences, Jodhpur. Written informed consent was taken from all the study participants. All participants were given the right to withdraw from the study at any point in time. The institutional ethics committee of AIIMS, Jodhpur, approved this study. The expression analysis of the klotho gene and miRNA – 339-5p was performed using a reverse transcription polymerase chain reaction. The relative fold change expression was calculated by Livaak’s method ( 2^-double delta ct). RESULTS: In Schizophrenia cases, serum Klotho protein levels were higher than healthy controls, though non-significant. We observed that the klotho gene was upregulated (figure 1), and miRNA- 339- 5p was downregulated (figure 2) compared to the healthy control. Image: Image 2: CONCLUSIONS: The present study is the first to evaluate the klotho gene expression and correlate it with miRNA- 339- 5p. Our study found increased expression of the klotho gene in Schizophrenia patients as compared to the controls. In this study, we also observed that miRNA- 339- 5p was downregulated, which correlates with the klotho gene expression inversely. However, these are the preliminary findings due to less sample size and need to be replicated in the large sample size for further confirmation. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10596670/ http://dx.doi.org/10.1192/j.eurpsy.2023.590 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Yadav, D.
Birdi, A.
Tomo, S.
Nebhinani, N.
Sharma, P.
Association of Klotho gene Expression and miRNA- 339 in Schizophrenia
title Association of Klotho gene Expression and miRNA- 339 in Schizophrenia
title_full Association of Klotho gene Expression and miRNA- 339 in Schizophrenia
title_fullStr Association of Klotho gene Expression and miRNA- 339 in Schizophrenia
title_full_unstemmed Association of Klotho gene Expression and miRNA- 339 in Schizophrenia
title_short Association of Klotho gene Expression and miRNA- 339 in Schizophrenia
title_sort association of klotho gene expression and mirna- 339 in schizophrenia
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596670/
http://dx.doi.org/10.1192/j.eurpsy.2023.590
work_keys_str_mv AT yadavd associationofklothogeneexpressionandmirna339inschizophrenia
AT birdia associationofklothogeneexpressionandmirna339inschizophrenia
AT tomos associationofklothogeneexpressionandmirna339inschizophrenia
AT nebhinanin associationofklothogeneexpressionandmirna339inschizophrenia
AT sharmap associationofklothogeneexpressionandmirna339inschizophrenia